Study results for Namisol® phase II trial

Medical Marijuana in the treatment of Multiple Sclerosis.

Study results for Namisol® phase II trial

Postby MSUK » Fri Jul 12, 2013 1:52 am

Study results for Namisol®, an oral mediation for spasticity and pain in MS announced

Echo Pharmaceuticals announced that Namisol® has completed successfully a Phase II trial with 24 patients suffering from spasticity and pain due to multiple sclerosis (MS). The trial has been conducted by the Centre for Human Drug Research (CHDR) in the VU University Medical Center Amsterdam and it was led by Dr. G.J. Groeneveld, Research Director Neurology & Pain, CHDR.

The clinical trial was a double blind, placebo-controlled study of Namisol® to determine safety, tolerability and efficacy in MS patients. The outcome of this trial showed efficacy and consistent results on both spasticity and pain........ Read More -
User avatar
Family Elder
Posts: 2839
Joined: Wed Oct 14, 2009 3:00 pm


Re: Study results for Namisol® phase II trial

Postby PointsNorth » Fri Jul 12, 2013 9:25 am

Just the beginning for cannabis in MS and many other diseases.

This link worked better for me. ... -appoints-

Thanks Squiff
Albany 2010. Brooklyn 2011
Hayes inspired Calcitriol+D3 2013-2014
Coimbra Protocol 2014-16
DrG B12 Transdermal Spray 2014-16
Progesterone 2015-16
Low-Dose Immunotherapy 2015-16
My Current Regimen
Family Elder
Posts: 683
Joined: Mon Sep 04, 2006 3:00 pm
Location: LeftCoast Canada

Return to Medical Marijuana


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service